Major Pharmaceuticals has recalled 3,161 cartons of Doxycycline Hyclate Tablets, USP (100 mg), which is a prescription antibiotic used to treat bacterial infections. The medication was found to fail dissolution specifications, meaning the tablets may not break down and release the active ingredient as designed once swallowed. This defect could lead to decreased effectiveness of the antibiotic treatment, potentially allowing an infection to persist. Consumers who have this medication should contact their healthcare provider or pharmacist and return the product for a refund.
If the medication fails to dissolve correctly in the digestive tract, the patient may not absorb the full dose of the antibiotic, which could result in treatment failure and the worsening of an underlying infection.
Healthcare consultation and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.